Kepos Capital’s Eli Lilly LLY Stock Holding History

Kepos Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,980	Closed	-$392K	–	255
2019 Q4	$392K	Buy	+2,980	New	+$345K	0.04%	254
2019 Q3	–	Sell	-22,454	Closed	-$2.49M	–	369
2019 Q2	$2.49M	Sell	22,454 -25,454	-53%	-$3M	0.25%	96
2019 Q1	$6.22M	Buy	+47,908	New	+$5.83M	0.47%	50
2018 Q3	–	Sell	-76,768	Closed	-$6.55M	–	388
2018 Q2	$6.55M	Buy	+76,768	New	+$6.31M	0.33%	51
2017 Q4	–	Sell	-11,356	Closed	-$971K	–	186
2017 Q3	$971K	Buy	+11,356	New	+$931K	0.16%	58

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Kepos Capital's LLY Position: Q1 2020 in Review

Kepos Capital sold out of Eli Lilly (LLY) in Q1 2020, closing a stake of 2,980 shares — an estimated $392K sold.

Kepos Capital first reported a position in LLY in Q3 2017 and held it in 5 quarters. The position peaked at $6.55M in Q2 2018. 1,684 funds tracked by Wall St. Rank hold LLY as of Q1 2020.

Kepos Capital reported no remaining Eli Lilly position as of Q1 2020 after selling out during the quarter.
Kepos Capital sold 2,980 Eli Lilly shares in Q1 2020, an estimated $392K.
Kepos Capital first reported a position in Eli Lilly in Q3 2017 and held it in 5 quarters.
Kepos Capital's Eli Lilly position peaked at $6.55M in Q2 2018.
1,684 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2020.

Based on Kepos Capital's 13F filing for Q1 2020, filed 12 May 2020.